KBR Stock Cash Flow Statements

KBR Quarterly Cash Flow Statements Chart

Quarterly

Annual

KBR Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-07-04	2025-04-04	2025-01-03	2024-09-27	2024-06-28	2024-03-29	2023-12-29	2023-09-29	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31

cash flows from operating activities:
net income	58,000,000	115,000,000	78,000,000	102,000,000	107,000,000	94,000,000	21,000,000	-18,000,000	-350,000,000	86,000,000	95,000,000	73,000,000	94,000,000	-70,000,000	69,000,000	58,000,000	-149,000,000	48,000,000	20,000,000	52,000,000	-39,000,000	-84,000,000	59,000,000	58,000,000	50,000,000	42,000,000	49,000,000	60,000,000	62,000,000	139,000,000	278,000,000	47,000,000	79,000,000	38,000,000	-86,000,000	-57,000,000	47,000,000	45,000,000	48,000,000	59,000,000	68,000,000	51,000,000	-1,231,000,000	45,000,000	8,000,000	-20,000,000	32,000,000	87,000,000	111,000,000	97,000,000	52,000,000	-60,000,000	112,000,000	98,000,000	105,000,000	191,000,000	127,000,000	117,000,000	97,000,000	117,000,000	122,000,000	59,000,000	89,000,000	97,000,000			88,000,000	85,000,000	48,000,000	98,000,000	71,000,000	63,000,000	140,000,000	28,000,000
less: net (income) income from discontinued operations, net of tax
net income from continuing operations
depreciation and amortization	45,000,000	41,000,000	44,000,000	41,000,000	35,000,000	36,000,000	37,000,000	34,000,000	34,000,000	36,000,000	38,000,000	33,000,000	33,000,000	33,000,000	32,000,000	38,000,000	38,000,000	38,000,000	41,000,000	26,000,000	21,000,000	27,000,000	28,000,000	28,000,000	23,000,000	25,000,000	16,000,000	17,000,000	17,000,000	13,000,000	10,000,000	11,000,000	14,000,000	13,000,000	14,000,000	12,000,000	10,000,000	9,000,000	10,000,000	10,000,000	8,000,000	11,000,000	17,000,000	19,000,000	18,000,000	18,000,000	19,000,000	18,000,000	16,000,000	15,000,000	17,000,000	15,000,000	17,000,000	16,000,000	17,000,000	19,000,000	18,000,000	17,000,000	17,000,000	16,000,000	14,000,000	15,000,000	14,000,000	13,000,000	14,000,000	14,000,000	16,000,000	16,000,000	9,000,000	8,000,000	11,000,000	6,000,000	11,000,000	13,000,000
equity in earnings of unconsolidated affiliates	-51,000,000	-42,000,000		-27,000,000	-40,000,000	-30,000,000												-12,000,000	0	-13,000,000	-16,000,000	-1,000,000	-11,000,000	-9,000,000			-27,000,000	-21,000,000	-10,000,000	-23,000,000	-8,000,000	-23,000,000	-32,000,000	-9,000,000	-10,000,000	-19,000,000	-33,000,000	-29,000,000	-26,000,000	-35,000,000	-53,000,000	-35,000,000	-45,000,000	-38,000,000	-49,000,000	-31,000,000	-30,000,000	-31,000,000	-46,000,000	-30,000,000	-38,000,000	-43,000,000	-33,000,000	-37,000,000	-50,000,000	-23,000,000	-41,000,000	-44,000,000	-38,000,000	-23,000,000	-61,000,000	-15,000,000	1,000,000	1,000,000	-26,000,000	-21,000,000	-54,000,000	-13,000,000
deferred income tax	13,000,000	13,000,000		5,000,000	7,000,000	11,000,000		5,000,000	5,000,000	14,000,000		16,000,000	17,000,000	16,000,000		3,000,000	28,000,000	7,000,000		5,000,000
gain on disposition of assets					0	-6,000,000					3,000,000				-1,000,000	-3,000,000	1,000,000	1,000,000								-4,000,000									-1,000,000	0			-27,000,000	-6,000,000
other	6,000,000	-2,000,000	17,000,000	1,000,000	14,000,000	9,000,000	15,000,000	18,000,000	3,000,000	10,000,000	9,000,000	9,000,000	3,000,000	12,000,000	17,000,000	16,000,000	12,000,000	11,000,000	18,000,000	17,000,000	7,000,000	1,000,000	14,000,000	8,000,000	16,000,000	-4,000,000	11,000,000	7,000,000	-5,000,000	11,000,000	9,000,000	9,000,000	5,000,000	6,000,000	-7,000,000	4,000,000	-2,000,000	8,000,000	-8,000,000	19,000,000	9,000,000	1,000,000	-14,000,000	4,000,000	9,000,000	12,000,000	3,000,000	9,000,000	1,000,000	8,000,000	-13,000,000	31,000,000	7,000,000	10,000,000	6,000,000	3,000,000	4,000,000	1,000,000	-1,000,000	11,000,000	12,000,000	8,000,000	4,000,000	8,000,000	-11,000,000	13,000,000	66,000,000	27,000,000	14,000,000	-31,000,000	9,000,000	9,000,000	24,000,000	19,000,000
changes in operating assets and liabilities:
accounts receivable, net of allowance for credit losses	-56,000,000	-72,000,000	2,000,000	12,000,000	15,000,000	-30,000,000	42,000,000	-2,000,000	58,000,000	-130,000,000	-20,000,000	114,000,000	-9,000,000	370,000,000	-135,000,000	-312,000,000	-53,000,000	24,000,000	177,000,000	-10,000,000
contract assets	-1,000,000	-5,000,000	-64,000,000	9,000,000	-15,000,000	-26,000,000	1,000,000	21,000,000	29,000,000	-7,000,000	-19,000,000	-26,000,000	1,000,000	14,000,000	2,000,000	-46,000,000	-1,000,000	-3,000,000	-10,000,000	11,000,000	23,000,000	15,000,000	21,000,000	-35,000,000	-16,000,000	-1,000,000	29,000,000	34,000,000	6,000,000	-44,000,000
accounts payable	20,000,000	5,000,000	54,000,000	17,000,000	-1,000,000	78,000,000	-95,000,000	-31,000,000	-33,000,000	110,000,000	64,000,000	-74,000,000	34,000,000	-400,000,000	50,000,000	332,000,000	32,000,000	33,000,000	-55,000,000	-8,000,000	-102,000,000	125,000,000	-60,000,000	16,000,000	28,000,000	39,000,000	40,000,000	36,000,000	-27,000,000	63,000,000	-49,000,000	-18,000,000	-51,000,000	-75,000,000	-45,000,000	7,000,000	41,000,000	-9,000,000	-35,000,000	-104,000,000	-33,000,000	-102,000,000	33,000,000	-12,000,000	-11,000,000	-20,000,000	113,000,000	-33,000,000	-48,000,000	17,000,000	-131,000,000	65,000,000	56,000,000	-4,000,000	-83,000,000	0	2,000,000	-29,000,000	-52,000,000	-60,000,000	-37,000,000	-28,000,000	-122,000,000	-108,000,000	-71,000,000	-54,000,000	316,000,000	-165,000,000	-8,000,000	71,000,000	-1,000,000	25,000,000	-32,000,000	-84,000,000
contract liabilities	3,000,000	-5,000,000	-37,000,000	15,000,000	3,000,000	-8,000,000	15,000,000	17,000,000	44,000,000	6,000,000	-22,000,000	-39,000,000	12,000,000	24,000,000	24,000,000	15,000,000	6,000,000	-62,000,000	-10,000,000	-32,000,000	-33,000,000	-59,000,000	-63,000,000	56,000,000	22,000,000	4,000,000	3,000,000	-5,000,000	-26,000,000	-32,000,000
accrued salaries, wages and benefits	-29,000,000	20,000,000	-38,000,000	9,000,000	58,000,000	-35,000,000	30,000,000	-14,000,000	42,000,000	-36,000,000	0	33,000,000	26,000,000	-43,000,000	-3,000,000	28,000,000	4,000,000	9,000,000	-8,000,000	24,000,000	-9,000,000	31,000,000	-40,000,000	12,000,000	10,000,000	9,000,000	-7,000,000	14,000,000	2,000,000	2,000,000	-25,000,000	37,000,000	-14,000,000	16,000,000	-31,000,000	-8,000,000	9,000,000	-20,000,000	-3,000,000	-9,000,000			-13,000,000	-15,000,000
payments on operating lease obligation	-22,000,000	-19,000,000		-20,000,000	-16,000,000	-16,000,000		-21,000,000	-12,000,000	-17,000,000		-15,000,000	-15,000,000	-14,000,000		-16,000,000	-15,000,000	-15,000,000
payments from unconsolidated affiliates	1,000,000	4,000,000	4,000,000	0			5,000,000	7,000,000	0	6,000,000	0	6,000,000	1,000,000	7,000,000	-1,000,000	8,000,000	3,000,000	7,000,000						4,000,000	4,000,000	1,000,000		1,000,000	5,000,000	1,000,000
distributions of earnings from unconsolidated affiliates	36,000,000	88,000,000	40,000,000	24,000,000	56,000,000	43,000,000	16,000,000	21,000,000	13,000,000	24,000,000	9,000,000	14,000,000	13,000,000	30,000,000	10,000,000	11,000,000	18,000,000	8,000,000					5,000,000	19,000,000	38,000,000	7,000,000	59,000,000	7,000,000	8,000,000	1,000,000	21,000,000	11,000,000	16,000,000	14,000,000	13,000,000	15,000,000	8,000,000	20,000,000	8,000,000	12,000,000	35,000,000	37,000,000	37,000,000	153,000,000	40,000,000	19,000,000		50,000,000	60,000,000	41,000,000
pension funding			-32,000,000	-12,000,000	-11,000,000	-7,000,000	0	0	-5,000,000	-4,000,000	-42,000,000	-10,000,000	-11,000,000	-11,000,000	-11,000,000	-11,000,000	-13,000,000	-11,000,000					-14,000,000	-12,000,000	-10,000,000	-9,000,000	-11,000,000	-11,000,000	-9,000,000	-10,000,000	-9,000,000	-10,000,000	-9,000,000	-9,000,000	-10,000,000	-10,000,000	-11,000,000	-10,000,000	-11,000,000	-16,000,000	-10,000,000	-11,000,000	-11,000,000	-13,000,000	-12,000,000	-12,000,000
other assets and liabilities	134,000,000	-43,000,000	30,000,000	-21,000,000	-47,000,000	-22,000,000	-7,000,000	-15,000,000	-10,000,000	-40,000,000	2,000,000	-5,000,000	-23,000,000	7,000,000	-34,000,000	5,000,000	14,000,000	-26,000,000	-93,000,000	22,000,000	70,000,000	58,000,000	-9,000,000	-21,000,000	-31,000,000	-23,000,000	7,000,000	-5,000,000	6,000,000	-38,000,000	-40,000,000	0	-2,000,000	-15,000,000	91,000,000	24,000,000	-24,000,000	-23,000,000	0	19,000,000	19,000,000	-21,000,000	41,000,000	50,000,000	12,000,000	-28,000,000
total cash flows from operating activities - continuing operations
cash flows from investing activities:
purchases of property, plant and equipment	-7,000,000	-9,000,000	-23,000,000	-19,000,000	-10,000,000	-25,000,000	-20,000,000	-22,000,000	-19,000,000	-19,000,000	-32,000,000	-20,000,000	-13,000,000	-6,000,000	-8,000,000	-6,000,000	-10,000,000	-6,000,000	-12,000,000	-4,000,000	-2,000,000	-2,000,000	-10,000,000	-4,000,000	-4,000,000	-2,000,000	-2,000,000	-4,000,000	-2,000,000	-9,000,000	-2,000,000	0	-3,000,000	-3,000,000	-3,000,000	-2,000,000	-3,000,000	-3,000,000	-2,000,000	-4,000,000	-3,000,000	-1,000,000	-7,000,000	-12,000,000	-19,000,000	-15,000,000
proceeds from sale of assets or investments				0	0	6,000,000						0	42,000,000	18,000,000													24,000,000	0			0	0			0	1,000,000				48,000,000
return of equity method investments
acquisition of businesses, net of cash acquired																				0	0	-9,000,000						3,000,000				0	0	2,000,000																																	-28,000,000	-487,000,000
total cash flows from investing activities - continuing operations
cash flows from financing activities:
borrowings on long-term debt				550,000,000	0	24,000,000		100,000,000												246,000,000	0	113,000,000
borrowings on revolver	98,000,000	275,000,000	50,000,000	175,000,000	75,000,000	93,000,000
payments on short-term and long-term debt	-9,000,000	-9,000,000	-43,000,000	0	-6,000,000	-75,000,000	-5,000,000	-4,000,000	-4,000,000	-4,000,000	-4,000,000	-4,000,000
payments on revolver	-228,000,000	-95,000,000	-35,000,000	-50,000,000
payments to repurchase common stock	-48,000,000	-156,000,000
payments on settlement of warrants			0	0	0	-33,000,000	-116,000,000	0
debt issuance costs			0	-2,000,000	0	-16,000,000													-2,000,000	0	0	-3,000,000					-10,000,000	-1,000,000
payments of dividends to shareholders	-21,000,000	-20,000,000	-20,000,000	-20,000,000	-21,000,000	-18,000,000	-19,000,000	-18,000,000	-19,000,000	-16,000,000	-17,000,000	-17,000,000	-17,000,000	-15,000,000	-16,000,000	-15,000,000	-16,000,000	-14,000,000	-14,000,000	-14,000,000	-15,000,000	-11,000,000	-12,000,000	-11,000,000	-12,000,000	-11,000,000	-10,000,000	-11,000,000	-12,000,000	-11,000,000	-11,000,000	-11,000,000	-11,000,000	-12,000,000	-12,000,000	-11,000,000	-12,000,000	-11,000,000	-12,000,000	-12,000,000	-11,000,000	-12,000,000	-12,000,000	-11,000,000	-12,000,000	-12,000,000	-12,000,000	-12,000,000			-15,000,000	-7,000,000	-8,000,000	-7,000,000	-7,000,000	-8,000,000	-7,000,000	-8,000,000	-8,000,000	-8,000,000	-8,000,000	-8,000,000	-8,000,000	-8,000,000	-8,000,000	-8,000,000	-8,000,000
total cash flows used in financing activities - continuing operations
total operating cash flows from discontinued operations
total investing cash flows from discontinued operations
total financing cash flows from discontinued operations
total cash flows from discontinued operations
effect of exchange rate changes on cash	11,000,000	9,000,000	-26,000,000	13,000,000	0	-1,000,000	9,000,000	-5,000,000	5,000,000	4,000,000	26,000,000	-19,000,000	-15,000,000	-7,000,000			2,000,000	3,000,000	20,000,000	8,000,000	2,000,000	-21,000,000	20,000,000			7,000,000	-10,000,000	6,000,000	-25,000,000	1,000,000	-1,000,000	4,000,000	4,000,000	5,000,000			-7,000,000	5,000,000	-6,000,000	-16,000,000	7,000,000	-28,000,000	-31,000,000	-36,000,000	9,000,000	6,000,000	8,000,000	11,000,000	-32,000,000	-21,000,000	0	16,000,000	-15,000,000	8,000,000	2,000,000	-16,000,000	-4,000,000	13,000,000	-5,000,000	33,000,000	-8,000,000	-13,000,000	-7,000,000	2,000,000	18,000,000	-6,000,000	-38,000,000	-22,000,000	0	20,000,000				-16,000,000
increase in cash and cash equivalents	-38,000,000	92,000,000	-112,000,000	48,000,000	100,000,000	10,000,000	-44,000,000	-191,000,000	123,000,000	27,000,000	-72,000,000	-55,000,000	104,000,000	42,000,000
cash and cash equivalents at beginning of period	0	350,000,000		0	0	304,000,000		0	0	389,000,000		0	0	370,000,000
cash and cash equivalents at end of period	-38,000,000	442,000,000		48,000,000	100,000,000	314,000,000		-191,000,000	123,000,000	416,000,000		-55,000,000	104,000,000	412,000,000
less: cash and cash equivalents of discontinued operations
cash and cash equivalents at end of period for continuing operations
supplemental disclosure of cash flows information:
noncash financing activities
dividends declared	-1,000,000	22,000,000	0	0	0	20,000,000	-1,000,000	1,000,000	0	18,000,000	0	-1,000,000	0	17,000,000	0	0	-1,000,000	16,000,000	0	0	0	14,000,000	0	0	0	11,000,000	0	0	0	11,000,000	0	0	-1,000,000	12,000,000	0	0	1,000,000	11,000,000	0	0	0	12,000,000	0	0	0	12,000,000	0	0				0	1,000,000	7,000,000		0	0	8,000,000
adjustments to reconcile net income to net cash from operating activities:
total cash flows from operating activities		98,000,000	40,000,000	161,000,000	170,000,000	91,000,000	83,000,000	-40,000,000	253,000,000	35,000,000	60,000,000	122,000,000	125,000,000	89,000,000	2,000,000	122,000,000	104,000,000	50,000,000	122,000,000	95,000,000	109,000,000	41,000,000	57,000,000	118,000,000	33,000,000	48,000,000	129,000,000	72,000,000			-45,000,000	28,000,000			53,000,000				132,000,000	54,000,000			-8,000,000	158,000,000			209,000,000				153,000,000	44,000,000	52,000,000	-107,000,000	338,000,000	89,000,000	-2,000,000	225,000,000	8,000,000	109,000,000			-9,000,000			-172,000,000	123,000,000	285,000,000	-352,000,000	68,000,000	76,000,000	-302,000,000
total cash flows from investing activities		-9,000,000			-3,000,000	11,000,000	-27,000,000	-22,000,000	-63,000,000	42,000,000	-49,000,000	-83,000,000	157,000,000	12,000,000												-69,000,000				125,000,000					-59,000,000	-895,000,000			53,000,000	29,000,000																											-37,000,000	-495,000,000			-10,000,000	-8,000,000
total cash flows used in financing activities		-6,000,000			-67,000,000	-91,000,000		-124,000,000	-72,000,000	-54,000,000		-75,000,000	-163,000,000	-52,000,000			-52,000,000	-22,000,000			-28,000,000	-155,000,000											-246,000,000	-15,000,000			-20,000,000	-18,000,000	-64,000,000	-30,000,000	-23,000,000	-75,000,000	-32,000,000	-31,000,000	-63,000,000	-84,000,000	-65,000,000	-14,000,000	-54,000,000	-15,000,000	-48,000,000	-19,000,000	-34,000,000	-15,000,000	-53,000,000	-76,000,000			-78,000,000	-175,000,000			-74,000,000	-33,000,000	-18,000,000	-41,000,000	-13,000,000	-214,000,000	-10,000,000	-7,000,000	-2,000,000	1,000,000
charges associated with convertible notes							66,000,000	114,000,000
equity in (earnings) losses of unconsolidated affiliates							-36,000,000	-32,000,000	-23,000,000	-23,000,000				118,000,000	-5,000,000	1,000,000
deferred income tax expense																						-10,000,000				3,000,000		-5,000,000	9,000,000	25,000,000				5,000,000	11,000,000	0	5,000,000	2,000,000							5,000,000	6,000,000		-33,000,000	22,000,000	81,000,000		4,000,000	32,000,000	25,000,000
gain on other investment
changes in operating assets and liabilities, net of acquired businesses:
payments on operating lease liabilities
net proceeds from sale of assets or investments
acquisitions of businesses, net of cash acquired
funding in other investment			0				0	0
borrowings on short-term and long-term debt
proceeds from the settlement of note hedge							343,000,000	0
payments to settle convertible notes							-593,000,000	0
payments to reacquire common stock			-51,000,000	-9,000,000	-97,000,000	-61,000,000	-1,000,000	0	-76,000,000	-61,000,000	-79,000,000	-50,000,000	-41,000,000	-33,000,000	-24,000,000	-26,000,000	-28,000,000	-4,000,000	-47,000,000	0	0	-4,000,000	0	-1,000,000	0	-3,000,000	0	0	-1,000,000	-2,000,000	-1,000,000	0	-50,000,000	-2,000,000	-2,000,000	0	0	-2,000,000	-40,000,000	-5,000,000	-1,000,000	-16,000,000	-4,000,000	-6,000,000	-40,000,000	-56,000,000		-1,000,000	0	-6,000,000	-4,000,000	-11,000,000	-18,000,000	-7,000,000	-22,000,000	-59,000,000	-35,000,000	-2,000,000	-16,000,000	-159,000,000	-57,000,000	-1,000,000	-4,000,000	-6,000,000	-5,000,000	-16,000,000	0
acquisition of noncontrolling interest			0																											-6,000,000									0	0	0	-40,000,000													-14,000,000	0	0	-164,000,000
total cash flows from financing activities			-101,000,000												227,000,000				184,000,000					-19,000,000	-61,000,000	-17,000,000		80,000,000	421,000,000	51,000,000	-18,000,000				-16,000,000																							-202,000,000				1,000,000												-142,000,000
cash and equivalents at beginning of period															0	0	0	436,000,000	0	0	0	712,000,000	0	0	0	739,000,000	0	0	0	439,000,000	0	0	0	536,000,000	0	0	0	883,000,000	0	0	0	970,000,000	0	0	0	1,106,000,000	0	0	0	1,053,000,000	0	0	0	966,000,000	0	0	0	786,000,000	0	0	0	941,000,000	0	0	0	1,145,000,000	0	0	0	1,861,000,000	0	0	0	1,461,000,000
cash and equivalents at end of period															-180,000,000	67,000,000	38,000,000	445,000,000	-513,000,000	314,000,000	69,000,000	566,000,000	31,000,000	70,000,000	-97,000,000	708,000,000	158,000,000	62,000,000	33,000,000	486,000,000	-72,000,000	20,000,000	81,000,000	410,000,000	-33,000,000	-235,000,000	-20,000,000	824,000,000	115,000,000	37,000,000	-27,000,000	758,000,000	-78,000,000	79,000,000	-27,000,000	996,000,000	140,000,000	159,000,000	-104,000,000	904,000,000	207,000,000	22,000,000	-13,000,000	837,000,000	276,000,000	-22,000,000	-76,000,000	788,000,000	-389,000,000	-60,000,000	327,000,000	908,000,000	-79,000,000	-57,000,000	156,000,000	921,000,000	35,000,000	-446,000,000	-371,000,000	1,927,000,000	66,000,000	-221,000,000	729,000,000	1,287,000,000
cash paid for interest																							26,000,000	17,000,000	21,000,000	16,000,000	18,000,000	16,000,000	15,000,000	3,000,000	5,000,000	5,000,000	5,000,000	6,000,000	5,000,000	3,000,000	2,000,000	2,000,000	2,000,000	3,000,000	2,000,000	3,000,000	2,000,000	3,000,000	3,000,000	3,000,000	3,000,000	3,000,000	3,000,000	3,000,000
cash paid for income taxes																							7,000,000	18,000,000	24,000,000	5,000,000	1,000,000	4,000,000	12,000,000	4,000,000	16,000,000	3,000,000	122,000,000	3,000,000	18,000,000	0	24,000,000	7,000,000	10,000,000	-7,000,000	35,000,000	28,000,000	24,000,000	9,000,000	-25,000,000	29,000,000	20,000,000	23,000,000	67,000,000	17,000,000
return of (investments in) equity method joint ventures				0	7,000,000	29,000,000	-1,000,000	0	0	61,000,000	0	9,000,000
acquisition of business, net of cash acquired																																																												0
total cash flows used in investing activities															-406,000,000	16,000,000	-16,000,000	-22,000,000	-839,000,000	-13,000,000	-14,000,000	-11,000,000	-10,000,000	-17,000,000			-63,000,000	-96,000,000				-1,000,000	-2,000,000	-1,000,000				-25,000,000				-1,000,000		-12,000,000	-10,000,000	-15,000,000		-16,000,000	-14,000,000	-20,000,000		-19,000,000	-16,000,000	-15,000,000	-11,000,000	-19,000,000	-24,000,000	-34,000,000	-314,000,000	-27,000,000	-18,000,000	-38,000,000		-7,000,000	-8,000,000	-5,000,000				-15,000,000				-13,000,000
legal settlement of legacy matter
deferred income tax (benefit) expense																															-247,000,000	10,000,000								17,000,000			355,000,000
unrealized gain on other investment
restructuring reserve											-4,000,000	-2,000,000	-3,000,000	-4,000,000	-6,000,000	-6,000,000	-7,000,000	-7,000,000	57,000,000	-6,000,000	10,000,000	28,000,000
payments on revolving credit facility							-70,000,000	-195,000,000			-61,000,000	0
net proceeds from issuance of common stock							0	1,000,000	2,000,000	2,000,000	0	0	1,000,000	4,000,000	1,000,000	1,000,000	6,000,000	4,000,000	1,000,000	0	1,000,000	2,000,000	2,000,000	1,000,000	1,000,000	1,000,000	0	1,000,000											0	0	0	1,000,000	0	0	0	4,000,000																						1,000,000	1,000,000	1,000,000
distributions to noncontrolling interests											0				0	-21,000,000			-1,000,000	-1,000,000			-8,000,000	-2,000,000							-3,000,000	0	0	-1,000,000	0	0	-3,000,000	-6,000,000	-7,000,000	-9,000,000	-5,000,000	-7,000,000				-19,000,000	-59,000,000	-3,000,000	-35,000,000	-11,000,000	-27,000,000	-2,000,000	-2,000,000	-5,000,000	-6,000,000	-11,000,000	-9,000,000	-37,000,000
noncash investing activities
leasehold improvements paid by landlord							0	2,000,000	0	7,000,000
accrued but unpaid purchases of property, plant and equipment							1,000,000	-6,000,000	-3,000,000	11,000,000
goodwill impairment																			0	0	37,000,000	62,000,000
asset impairments															1,000,000				7,000,000	1,000,000	26,000,000	64,000,000
claims receivable																															0	0
investment in other investment
acquisition of technology license															0	0	0	-7,000,000
borrowings on short-term and long term debt
borrowings on revolving credit facility
investments from noncontrolling interests
equity in losses of unconsolidated affiliates												-5,000,000
unrealized gain on cost method investment												0
investment in cost method investment												0
(gain) loss on disposition of assets
loss on disposition of assets
investments in equity method joint ventures														-1,000,000	-16,000,000	-6,000,000	-4,000,000	-3,000,000	-4,000,000	-10,000,000			0	-15,000,000	-61,000,000	-70,000,000	-87,000,000	-95,000,000
payments on short-term and long-term borrowings														-7,000,000	-19,000,000	-6,000,000	-12,000,000	-7,000,000	-11,000,000	-7,000,000	-11,000,000	-252,000,000	-16,000,000	-7,000,000			-93,000,000	-2,000,000			-4,000,000	0			-4,000,000	0				0			-4,000,000	0	-5,000,000	-2,000,000	-5,000,000	0											-4,000,000
borrowings on long term debt
borrowings on revolving credit agreement																														70,000,000					0
decrease in cash and equivalents																					69,000,000	-146,000,000									-72,000,000	20,000,000	81,000,000	-126,000,000	-33,000,000	-235,000,000	-20,000,000	-59,000,000		37,000,000	-27,000,000	-212,000,000		79,000,000				159,000,000	-104,000,000	-149,000,000		22,000,000										-55,000,000		-57,000,000										-174,000,000
proceeds from disposition of assets and investments																				0				2,000,000
increase in cash and equivalents																67,000,000	38,000,000	9,000,000	-513,000,000				31,000,000	70,000,000	-97,000,000	-31,000,000	158,000,000	62,000,000	33,000,000	47,000,000																-110,000,000								-129,000,000	276,000,000	-22,000,000	-76,000,000	2,000,000		-60,000,000						-224,000,000	35,000,000	-446,000,000	-371,000,000	66,000,000	66,000,000	-221,000,000
dollars in millions																0	0	2,021,000,000		0	0	2,020,000,000
current maturities of long-term debt																2,000,000	2,000,000	12,000,000		-1,000,000	1,000,000	12,000,000
reserve for estimated losses on uncompleted contracts																-3,000,000	2,000,000	16,000,000		3,000,000	3,000,000	9,000,000
retainage payable																-1,000,000	0	13,000,000		-24,000,000	4,000,000	46,000,000				2,000,000
income taxes payable																	-4,000,000	11,000,000		-20,000,000	-5,000,000	26,000,000				12,000,000	15,000,000	21,000,000	-5,000,000	12,000,000		-2,000,000	-11,000,000	6,000,000	-33,000,000	-9,000,000	-11,000,000	1,000,000	33,000,000	8,000,000	-4,000,000	-11,000,000	-8,000,000	2,000,000	33,000,000	-13,000,000
value-added tax payable																-7,000,000	12,000,000	31,000,000		-3,000,000	13,000,000	34,000,000
dividend payable																0	0	16,000,000		0	0	14,000,000
other miscellaneous liabilities																-1,000,000	8,000,000	55,000,000		4,000,000	-14,000,000	59,000,000
total other current liabilities																-21,000,000	16,000,000	182,000,000		-47,000,000	12,000,000	228,000,000
other investment																		-6,000,000
payment of contingent consideration liability																		-1,000,000
gain on consolidation of aspire subcontracting entities
adjustments to cash due to consolidation of aspire entities																											0	0
payments on revolving credit agreement																															0	0			0
proceeds from sale of warrants
purchase of note hedges
issuance of convertible notes
excess tax benefits from share-based compensation																																					0	1,000,000
acquisition of remaining ownership interest in joint ventures																											0	0
acquisition of technology licensing rights
gain on disposition of assets and investments																				0	1,000,000	-19,000,000		-1,000,000
accounts receivable, net of allowance for doubtful accounts																						-169,000,000	107,000,000	-5,000,000	-70,000,000	-48,000,000	-59,000,000	-74,000,000	64,000,000	-134,000,000	-8,000,000	30,000,000	32,000,000	38,000,000	112,000,000	-16,000,000	-29,000,000	54,000,000	60,000,000	30,000,000	-52,000,000	3,000,000	104,000,000	-27,000,000	-28,000,000	121,000,000
payments from (advances to) unconsolidated affiliates																															5,000,000	1,000,000	4,000,000	1,000,000				-8,000,000
kbr, inc.consolidated statements of cash flows
total cash flows provided (used) by financing activities
adjustments to cash due to consolidation of aspire subcontracting entities
kbr, inc.condensed consolidated statements of cash flows
borrowings on revolving credit agreements																												0
payments on revolving credit agreements																												0
gain on consolidation of aspire entities																											5,000,000	2,000,000	0	-115,000,000
reserve for loss on uncompleted contracts																										-1,000,000	-1,000,000	-3,000,000	-2,000,000	-3,000,000	-5,000,000	-8,000,000	-13,000,000	-22,000,000	10,000,000	8,000,000	-7,000,000	-16,000,000	6,000,000	-18,000,000	-45,000,000	-37,000,000	44,000,000	-4,000,000	-1,000,000	18,000,000	-13,000,000	-15,000,000	-6,000,000	-10,000,000	37,000,000	4,000,000	-3,000,000	-4,000,000	3,000,000	-3,000,000			-2,000,000	-2,000,000	-5,000,000	-4,000,000	-14,000,000	-7,000,000	-3,000,000	-13,000,000	-16,000,000	-13,000,000	-13,000,000	1,000,000				-32,000,000
subcontractor advances																										-3,000,000				-1,000,000
net settlement of derivative contracts																										-3,000,000	-5,000,000	-3,000,000	-2,000,000	3,000,000	-1,000,000	3,000,000	3,000,000	-2,000,000	-1,000,000	-5,000,000	1,000,000	-4,000,000	-4,000,000	-1,000,000	-3,000,000	-36,000,000
payments on long-term borrowings																										-2,000,000																										0				0															0	0	-2,000,000	-5,000,000
asset impairment
total cash flows used in operating activities																														-130,000,000				-115,000,000			9,000,000	-21,000,000				-108,000,000				-17,000,000			-4,000,000	-93,000,000												-5,000,000												-3,000,000
payments for investments in equity method joint ventures																														-72,000,000					-56,000,000
increase in cash due to consolidation of aspire entities																														205,000,000
costs and estimated earnings in excess of billings on uncompleted contracts																															29,000,000	-30,000,000	37,000,000	4,000,000	-17,000,000	53,000,000	-33,000,000	5,000,000	56,000,000	30,000,000	94,000,000	44,000,000	2,000,000	-21,000,000	-18,000,000	-70,000,000
billings in excess of costs and estimated earnings on uncompleted contracts																															9,000,000	-40,000,000	-43,000,000	-124,000,000	19,000,000	16,000,000	44,000,000	-46,000,000	8,000,000	33,000,000	-35,000,000	-8,000,000	91,000,000	45,000,000	23,000,000	-15,000,000
cash flows used in investing activities:
•
cash flows used in financing activities:
cash flows used in operating activities:
gain on negotiated settlement with former parent																																											0
impairment of goodwill																																																															0
(advances to) payments from unconsolidated affiliates																																			2,000,000	5,000,000
acquisition of technology businesses, net of cash acquired																																					0	-22,000,000
receipts of advances from unconsolidated affiliates																																							0	6,000,000	-2,000,000	6,000,000	-1,000,000	7,000,000	0	7,000,000
payment on performance bonds for epc 1 project in mexico
payment for investment in partnership																																							-4,000,000
proceeds from sale of assets and investments																																											0	0
payments on borrowings
noncash operating activities
other assets change for payments made on our behalf by former parent
other liabilities change for payments made on our behalf by former parent
cash flows from (used in) operating activities:
cash flows from (used in) investing activities:
cash flows from (used in) financing activities:
acquisition or disposition of businesses
return of capital from equity method joint ventures
distributions to noncontrolling interests, net of investments																																												-14,000,000
other assets change for barracuda arbitration																																																0	0	-219,000,000
other liabilities change for barracuda arbitration																																																0	0	219,000,000
excess tax benefits from stock-based compensation																																													0	1,000,000						-1,000,000	2,000,000	2,000,000	0	0	2,000,000	1,000,000									0	0	1,000,000	1,000,000	3,000,000
accrued salary, wages and benefits																																														-9,000,000
other assets change for barracuda arbitration and fcpa matters
other liabilities change for barracuda arbitration and fcpa matters
impairment of goodwill and long-lived assets
accounts receivable
collection (repayment) of advances from (to) unconsolidated affiliates																																															2,000,000				-4,000,000	1,000,000	0	-3,000,000	-1,000,000	-7,000,000	-1,000,000	23,000,000	-11,000,000	-1,000,000	-3,000,000	-1,000,000					-1,000,000	12,000,000
distributions of earnings received from unconsolidated affiliates
payment on performance bonds for the epc 1 project in mexico
(investment in)/return of capital from equity method joint ventures
purchases of treasury stock
return of cash collateral on letters of credit																																																								0	11,000,000	5,000,000				17,000,000
receivables																																																184,000,000	37,000,000	-95,000,000	74,000,000	-138,000,000	-75,000,000	130,000,000	128,000,000	149,000,000	-107,000,000	82,000,000	-31,000,000	32,000,000	255,000,000	-438,000,000	298,000,000	-126,000,000	158,000,000	-223,000,000	-5,000,000	115,000,000	-220,000,000	-14,000,000	104,000,000	-162,000,000	138,000,000	-223,000,000
unbilled receivables on uncompleted contracts																																																-15,000,000	31,000,000	-88,000,000	65,000,000	-11,000,000	-144,000,000	-148,000,000	139,000,000	-157,000,000	19,000,000	-27,000,000	55,000,000	73,000,000	-60,000,000	155,000,000	62,000,000	24,000,000	61,000,000	9,000,000	-118,000,000	72,000,000	-67,000,000	68,000,000	-7,000,000	29,000,000	290,000,000	-48,000,000
advance billings on uncompleted contracts																																																-78,000,000	-20,000,000	-5,000,000
accrued employee compensation and benefits																																																4,000,000	10,000,000	-28,000,000	41,000,000	4,000,000	-24,000,000	-29,000,000	41,000,000	-47,000,000	-1,000,000	38,000,000	-50,000,000	9,000,000	-24,000,000	74,000,000	-105,000,000	-28,000,000	-31,000,000	35,000,000	-38,000,000	49,000,000	-60,000,000	9,000,000				24,000,000
payment on performance bonds																																																0
capital expenditures																																																-17,000,000	-20,000,000	-20,000,000	-22,000,000	-20,000,000	-17,000,000	-16,000,000	-17,000,000	-19,000,000	-21,000,000	-26,000,000	-27,000,000	-20,000,000	-5,000,000	-14,000,000	-19,000,000	-6,000,000	-9,000,000	-7,000,000	-10,000,000	-11,000,000	-8,000,000	-8,000,000	-11,000,000	-9,000,000	-11,000,000	-12,000,000
free cash flows
acquisition of business																																																				1,000,000	0	-2,000,000
proceeds from sale of property, plant and equipment																																																1,000,000
net proceeds from issuance of stock																																																1,000,000	2,000,000	2,000,000	2,000,000	2,000,000	1,000,000	2,000,000	0	2,000,000	2,000,000	3,000,000	2,000,000	2,000,000
other financing activities																																																				0												2,000,000
supplemental disclosure of cash flow information:
repayment of advances to unconsolidated affiliates
millions of shares																																																		2,013,000,000		0	0	2,012,000,000							0	2,010,000,000		0
basic weighted-average common shares outstanding																																																		147,000,000		-1,000,000	0	148,000,000							0	160,000,000		0	-1,000,000	161,000,000
stock options and restricted shares																																																		1,000,000			0	1,000,000							0	1,000,000		0	0	1,000,000
diluted weighted-average common shares outstanding																																																		148,000,000		-2,000,000	0	149,000,000							0	161,000,000		0	-1,000,000	162,000,000
acquisition or disposition of businesses, net of cash acquired
(investment in) / return of capital from equity method joint ventures																																																			-1,000,000	0	1,000,000	3,000,000
investment in licensing arrangement																																																											0	0	0	-20,000,000
cash increase due to consolidation of a variable interest entity																																																											0	0	0	22,000,000
purchase of computer software																																																											0	0
obligation to former noncontrolling interest partner in mwkl
adjustments to reconcile net income to net cash from operations:
impairment of long-lived asset
other adjustments																																																				8,000,000	8,000,000	6,000,000
advanced billings on uncompleted contracts																																																				-29,000,000	64,000,000	-179,000,000		13,000,000	-82,000,000	80,000,000		-124,000,000	92,000,000	169,000,000						97,000,000	-75,000,000	-234,000,000		-114,000,000	4,000,000	197,000,000
distribution of earnings from unconsolidated affiliates																																																				13,000,000	35,000,000	12,000,000		46,000,000	52,000,000	9,000,000		16,000,000	20,000,000	9,000,000		18,000,000	3,000,000	14,000,000		12,000,000	35,000,000	41,000,000
deferred income taxes																																																							-37,000,000	-123,000,000	-22,000,000	9,000,000	23,000,000	11,000,000	-3,000,000	-17,000,000	79,000,000	19,000,000	-18,000,000	-15,000,000	36,000,000	29,000,000	4,000,000	19,000,000	-35,000,000	-14,000,000	19,000,000	3,000,000
impairment of long-lived assets
other assets																																																							-77,000,000	5,000,000	61,000,000	-17,000,000	-55,000,000	29,000,000	35,000,000	-3,000,000	-289,000,000	26,000,000	51,000,000	-52,000,000	-60,000,000	16,000,000	-11,000,000	-94,000,000	9,000,000	22,000,000	-69,000,000	9,000,000
other liabilities																																																							15,000,000	23,000,000	-27,000,000	-34,000,000	24,000,000	5,000,000	80,000,000	12,000,000	2,000,000	31,000,000	31,000,000	25,000,000	-37,000,000	-54,000,000	5,000,000	77,000,000	-22,000,000	-162,000,000	232,000,000	40,000,000
investment in equity method joint ventures																																																							0	0	-3,000,000	-8,000,000	2,000,000
proceeds from sale of investments
return (funding) of cash collateral on letters of credit																																																											2,000,000	2,000,000
obligation to former noncontrolling interest
millions of dollars
current restricted cash
non-current restricted cash
total restricted cash
noncash activities:
sales of property, plant and equipment																																																																			1,000,000				2,000,000	0
other investing activities																																																																-1,000,000	1,000,000	2,000,000			10,000,000	-7,000,000			0	-1,000,000
distributions to noncontrolling shareholders																																																												-7,000,000	-23,000,000	-7,000,000	-24,000,000	-21,000,000
dividends payable
investment in equity method joint venture																																																													-3,000,000	-4,000,000
dividends declared or payable																																																													0	8,000,000		0	0	8,000,000
dilutive effect of:
gain on sale of assets																																																																							0	0
dispositions of businesses, net of cash
payments to former parent
cash collateralization of letters of credit
intangibles not subject to amortization
intangibles subject to amortization
total intangibles
accumulated amortization of other intangibles
net intangibles
advanced billings and unearned revenue on uncompleted contracts																																																																11,000,000	-96,000,000	17,000,000
collection of advances from unconsolidated affiliates																																																																-4,000,000	1,000,000	2,000,000
net income attributable to kbr																																																																		77,000,000
payments of dividends to noncontrolling shareholders																																																																		-17,000,000
impairment of equity method investments																																																																									0	18,000,000
payments to halliburton																																																																							0
net repayments of short-term borrowings
proceeds from long-term borrowings
payments of dividends to minority shareholders																																																																			-5,000,000	-11,000,000	-3,000,000	-9,000,000	-7,000,000	-9,000,000	-5,000,000	-14,000,000
cash payments for interest paid to third party
cash payments for income taxes
indemnification receivables
government obligations
contribution from parent and other activities
kbr options
expected term
expected volatility
expected dividend yield
risk-free interest rate
weighted-average grant-date fair value per share
disposition of businesses/investments, net of cash disposed																																																																								0
dividends declared but not paid
cost of services																																																																				-14,000,000
general and administrative																																																																				2,000,000	1,000,000	29,000,000
payment of dividends to shareholders
cash dividends declared																																																																					0	9,000,000
equity earnings from unconsolidated affiliates																																																																						-21,000,000
collection of advances to unconsolidated affiliates																																																																						70,000,000
payments to (from) halliburton
in millions
cost of service																																																																						1,953,000,000
distributions from
cash payments during the year for:
interest paid to third party
income taxes
adjustments to reconcile net income to cash from operations:
equity in earnings (losses), net of distributions from related companies
reserve for estimated loss on uncompleted contracts																																																																								-13,000,000
employee compensation and benefits																																																																								26,000,000
proceeds on long-term borrowings
proceeds from issuance of common stock
effect of exchange rate changes																																																																								88,000,000
probable unapproved claims																																																																								2,000,000	-15,000,000	191,000,000
probable unapproved change orders																																																																								-2,000,000
probable unapproved claims related to unconsolidated subsidiaries																																																																								-45,000,000
probable unapproved change orders related to unconsolidated subsidiaries																																																																								-14,000,000
distribution from (to) related companies, net of equity in earnings (losses) of unconsolidated affiliates
payments from (to) halliburton																																																																									0	-123,000,000
distribution from																																																																										33,000,000
probable unapproved claims accrued revenue																																																																										188,000,000
probable unapproved claims from unconsolidated related companies																																																																										78,000,000
dispositions (acquisitions) of businesses, net of cash
payments to related party

We provide you with 20 years of cash flow statements for KBR stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of KBR stock. Explore the full financial landscape of KBR stock with our expertly curated income statements.

The information provided in this report about KBR stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.